5 Impfstoffe gemäß § 2 Abs. 1 Z 3, COVID-19-EinreiseV 2021

No longer in force

Comirnaty/BNT162b2/Tozinameran (INN) von BioNtech/Pfizer: 2 Dosen

ChAdOx1_nCoV-19/ChAdOx1-S/AZD1222/Vaxzevria/ COVID-19 Vaccine AstraZeneca von AstraZeneca, und Covishield von Serum Institute of India: 2 Dosen

COVID-19 Vaccine Janssen von Johnson & Johnson/Janssen Pharmaceuticals/Ad26.COV2.S Janssen (US +NL-Sites): 1 Dosis

Covid-19 Vaccine Moderna/mRNA-1273 von Moderna: 2 Dosen

Sinopharm / BIBP (Beijing Bio-Institute of Biological Products Co-Ltd.) SARS-CoV-2 Vaccine (Vero Cell), Inactivated (InCoV): 2 Dosen

Sinovac-CoronaVac vaccine, SARS-CoV-2 Vaccine (Vero Cell), Inactivated: 2 Dosen

COVAXIN/BBV152 von Bharat Biotech International Ltd: 2 Dosen

COVOVAX/NVX-CoV2373 von Serum Institute of India Pvt. Ltd: 2 Dosen

NUVAXOVID/NVX-CoV2373 von Novavax CZ a.s.: 2 Dosen

Changed on 25 Dec 2021

COVAXIN/BBV152 von Bharat Biotech International Ltd: 2 Dosen COVOVAX/NVX-CoV2373 von Serum Institute of India Pvt. Ltd: 2 Dosen NUVAXOVID/NVX-CoV2373 von Novavax CZ a.s.: 2 Dosen

  1. 25 Dec 2021 – 16 May 2022earlier wording
  2. 1 Jul 2021 – 25 Dec 2021earlier wording